Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Race Oncology Limited (RAONF)

1.2200
-1.3800
(-53.08%)
As of May 2 at 4:00:00 PM EDT. Market Open.
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
18,655.3830
18,655.3830
13,649.6450
11,963.7000
6,784.0510
Operating Income
-18,655.3830
-18,655.3830
-13,649.6450
-11,963.7000
-6,784.0510
Net Non Operating Interest Income Expense
832.5770
832.5770
591.8390
53.9150
18.8470
Other Income Expense
4,003.4700
4,003.4700
3,134.3810
707.8070
424.8850
Pretax Income
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Net Income Common Stockholders
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Basic EPS
-0.08
--
-0.06
-0.07
-0.05
Diluted EPS
-0.08
--
-0.06
-0.07
-0.05
Basic Average Shares
164,500.7210
--
160,720.6480
153,309.8570
130,963.6950
Diluted Average Shares
164,500.7210
--
160,720.6480
153,309.8570
130,963.6950
Net Income from Continuing & Discontinued Operation
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Normalized Income
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Interest Income
832.5770
832.5770
591.8390
53.9150
18.8470
Net Interest Income
832.5770
832.5770
591.8390
53.9150
18.8470
EBIT
-18,655.3830
-18,655.3830
-13,649.6450
-11,963.7000
-6,784.0510
EBITDA
-18,374.1870
-18,374.1870
-13,368.4490
-11,682.5040
-6,502.8550
Reconciled Depreciation
281.1960
281.1960
281.1960
281.1960
281.1960
Net Income from Continuing Operation Net Minority Interest
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Normalized EBITDA
-18,374.1870
-18,374.1870
-13,368.4490
-11,682.5040
-6,502.8550
6/30/2021 - 3/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1RT.F Nuformix plc
0.0010
0.00%
 
VAL.L ValiRx plc
0.5000
0.00%
 
ATNFW 180 Life Sciences Corp.
0.0078
+5.41%
 
HUMAW Humacyte, Inc.
0.3101
+6.93%
 
NFX.L Nuformix plc
0.1250
-5.66%
 
RGBP Regen BioPharma, Inc.
0.0625
+24.75%
 
OKYO OKYO Pharma Limited
1.4601
+7.76%
 
SRNE Sorrento Therapeutics, Inc.
0.0009
0.00%
 
HUMA Humacyte, Inc.
1.2800
-2.29%
 
TNXP Tonix Pharmaceuticals Holding Corp.
20.35
+1.76%